IQVIA Inc, founded in 2016 and headquartered in Durham, North Carolina, operates with the mission of leveraging advanced data analytics and technology to drive healthcare insights and outcomes. The company offers a wide range of services, including data analysis, clinical development, and commercial solutions tailored for the pharmaceutical and healthcare industries.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| IQV 1.75% 2026-03-15 EURIQVIA Inc | United States | 2026-03-15 | 1.750 | 0.00 |
| IQV 1.75% 2026-03-15 EURIQVIA Inc | United States | 2026-03-15 | 1.750 | 0.00 |
| IQV 2.25% 2028-01-15 EURIQVIA Inc | United States | 2028-01-15 | 2.250 | 3.94 |
| IQV 2.25% 2028-01-15 EURIQVIA Inc | United States | 2028-01-15 | 2.250 | 3.94 |
| IQV 2.25% 2029-03-15 EURIQVIA Inc | United States | 2029-03-15 | 2.250 | 4.08 |
| IQV 2.25% 2029-03-15 EURIQVIA Inc | United States | 2029-03-15 | 2.250 | 4.08 |
| IQV 2.88% 2028-06-15 EURIQVIA Inc | United States | 2028-06-15 | 2.875 | 3.96 |
| IQV 2.88% 2028-06-15 EURIQVIA Inc | United States | 2028-06-15 | 2.875 | 3.96 |
| IQV 5.00% 2027-05-15 USDIQVIA Inc | United States | 2027-05-15 | 5.000 | 5.29 |
| IQV 5.00% 2027-05-15 USDIQVIA Inc | United States | 2027-05-15 | 5.000 | 5.50 |
| IQV 5.70% 2028-05-15 USDIQVIA Inc | United States | 2028-05-15 | 5.700 | 4.66 |
| IQV 5.70% 2028-05-15 USDIQVIA Inc | United States | 2028-05-15 | 5.700 | 4.66 |
| IQV 5.70% 2028-05-15 USDIQVIA Inc | United States | 2028-05-15 | 5.700 | 4.53 |
| IQV 6.25% 2029-02-01 USDIQVIA Inc | United States | 2029-02-01 | 6.250 | 4.75 |
| IQV 6.25% 2032-06-01 USDIQVIA Inc | United States | 2032-06-01 | 6.250 | 6.03 |
| IQV 6.25% 2032-06-01 USDIQVIA Inc | United States | 2032-06-01 | 6.250 | 6.00 |
| IQV 6.50% 2030-05-15 USDIQVIA Inc | United States | 2030-05-15 | 6.500 | 6.08 |
| IQV 6.50% 2030-05-15 USDIQVIA Inc | United States | 2030-05-15 | 6.500 | 5.89 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
IQVIA began issuing bonds shortly after its formation, with significant issuances including a $1.3 billion bond in 2017 to refinance existing debt and support strategic initiatives. The company's bonds typically feature attractive yields compared to industry averages, reflecting its solid financial standing and growth potential. Notably, in 2021, IQVIA launched a $1 billion offering that was well-received by the market, indicating strong investor confidence. Current yields remain competitive, positioning IQVIA favorably within the healthcare analytics sector.